Trading Update

Avingtrans Plc                                 

                ("Avingtrans" or the "Company" or the "Group")                 

                                Trading Update                                 

Avingtrans (AIM:AVG), a manufacturer of critical components and associated
services to the global aerospace, energy and medical sectors is pleased to
announce an update on trading in light of the recent transactions completed by
the Group.

Summary of recent transactions (the "Recent Transactions")

On 5 November 2012, the Company announced the sale of Jena Tec, its Industrial
division, for a cash consideration of £13.45m and we also set out a clearly
defined strategy focussed on the Group's two core divisions: Aerospace and
Energy & Medical.

In line with this strategy, the Company subsequently announced the acquisitions
of certain assets of PFW Farnborough ("PFW") for £1.85m (announced 16 November)
and Aerotech Tubes ("Aerotech") for £2m (announced 26 November), which have
propelled the business into a leading position in Europe in the Aerospace pipes
market.

The sale of Jena Tec, and the subsequent acquisitions described above, provides
us with a more focused business, and a stronger balance sheet, which will
enable us to invest in each of these businesses and pursue opportunities which
we would otherwise have been unable to target. Consistent with this strategy,
we will continue to seek further value enhancing acquisitions to build on the
Group's position in our core Aerospace and Energy & Medical divisions.

Outlook

2013 Financial Year

Sales Revenues for the year are expected to be in line with original Board
expectations, with the loss of revenue replaced by revenue streams from PFW and
Aerotech in the second half of the 2013 financial year. However, in the short
term, the margins realised from sales at PFW and Aerotech will not compensate
for the loss of margin in respect of Jena Tec, which will impact profitability
for the 2013 financial year.

The Group will realise an exceptional profit in respect of the disposal of Jena
Tec of approximately £8m and will incur exceptional costs of £0.35m in respect
of the acquisitions of PFW and Aerotech.

Net debt for the full year will be materially lower than previous Board
expectations, with the cash proceeds received from the disposal of Jena Tec,
partially offset by the cash consideration in respect of the PFW and Aerotech
acquisitions, further capital investment, particularly in respect of China, and
the immediate working capital requirements at PFW. However, we have chosen not
to pay back all of the Group debt at this time - mortgages on properties and
equipment leases being left mostly intact.

2014 Financial Year

The Board is confident that the Group will see both revenue and margin
improvement during the 2014 financial year, which will deliver results
marginally above previous Board expectations. Coupled with an improved and more
robust balance sheet, the Board believes that the recent transformational
transactions place the Group in a much stronger position for the future, both
financially and strategically.

Interim dividend and results

Given the improved position of the Group, and to emphasise our confidence in
the future, the Board expects to reinstate an interim dividend of 0.7p when the
Company announces its results for the six months ended 30 November 2012.

The Company expects to release its interim results for the six months ended 30
November 2012 in the week commencing 25 February 2013.

Enquiries:

Avingtrans plc
                                                                                
 0115 949 9020

Steve McQuillan, CEO

Stephen King, CFO 

Numis Securities Limited 020 7260 1000

David Poutney (Corporate Broking)

Richard Thomas (Corporate Finance and Nominated Adviser)

                                                                             

Newgate Threadneedle
                                                                  020 7653 9850

(Financial PR)

Josh Royston

Heather Armstrong

About Avingtrans

Avingtrans plc is engaged in the provision of highly engineered components     
and services to the Aerospace, Energy and Medical markets worldwide.           
                                                                               
The business is made up of 2 divisions:                                        

Aerospace, engaged in the manufacture of rigid pipe assemblies, fabrications
and prismatic components - both metallic and composite - for the global
aerospace market and precision polishing of aircraft components and;

Energy and medical, engaged in the manufacture of machined and fabricated
pressure and vacuum vessels and components for the energy, medical, science and
research communities. Plus, design and manufacture of fabricated poles and
cabinets for roadside safety cameras and rail track signalling.